Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
122.22
-3.74 (-2.97%)
Apr 29, 2026, 9:31 AM EDT - Market open
Palvella Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 1,749 | 1,239 | 135 | - | - |
| Market Cap Growth | 629.63% | 820.07% | - | - | - |
| Enterprise Value | 1,763 | 1,191 | 215 | - | - |
| Last Close Price | 125.96 | 104.67 | 12.00 | - | - |
| PB Ratio | 55.73 | 44.27 | 2.15 | - | - |
| P/TBV Ratio | 64.43 | 44.27 | 2.15 | - | - |
| Debt / Equity Ratio | 0.66 | 0.66 | 0.19 | -2.08 | -1.40 |
| Net Debt / Equity Ratio | -1.41 | -1.41 | -1.14 | -0.18 | -0.71 |
| Quick Ratio | 5.11 | 5.11 | 7.14 | 3.11 | 2.78 |
| Current Ratio | 5.20 | 5.20 | 7.33 | 3.20 | 2.86 |
| Return on Equity (ROE) | -92.10% | -92.10% | -59.37% | - | - |
| Return on Assets (ROA) | -32.65% | -32.65% | -18.39% | -61.63% | - |
| Return on Capital Employed (ROCE) | -80.10% | -80.10% | -18.50% | -228.80% | -167.90% |
| Earnings Yield | -2.31% | -3.37% | -12.95% | - | - |
| Buyback Yield / Dilution | -405.46% | -405.46% | -24.08% | 68.63% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.